Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Immunotherapy

Background:

• Sonodynamic therapy (SDT) is an evolution of photodynamic therapy (PDT), utilizing nanoparticles (NPs) for enhanced tumor treatment.
• SDT offers advantages like deeper tissue penetration and reduced reliance on reactive oxygen species (ROS) for tumor cell killing.
• Current SDT limitations include tumor growth inhibition rather than shrinkage and inability to address metastatic disease.

Purpose of the Study:

• To review advancements in nanoparticle-based SDT and immune checkpoint blockade (ICB) therapy.
• To highlight the synergistic anti-tumor mechanisms of combined SDT and ICB.
• To summarize preclinical trials of SDT-assisted immunotherapy and discuss future directions.

Main Methods:

• Literature review of nanoparticle-based SDT and ICB therapies.
• Analysis of synergistic anti-tumor mechanisms.
• Summary of preclinical trial data for SDT-assisted immunotherapy.

Main Results:

• NPs-based SDT demonstrates improved penetration and safety compared to conventional PDT.
• The combination of SDT with ICB can overcome SDT's limitations, potentially leading to tumor shrinkage and immune memory.
• Preclinical trials show promising results for SDT-assisted immunotherapy, with innovative sonosensitizers being key.

Conclusions:

• Synergistic application of NPs-based SDT and ICB presents a promising strategy for solid tumor treatment.
• Further research into novel sonosensitizers and overcoming current challenges is crucial for clinical translation.
• This approach holds potential for inducing long-term anti-tumor immunity and preventing tumor recurrence.